# F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma

> **NCT05948137** · — · TERMINATED · sponsor: **Asan Medical Center** · enrollment: 32 (actual)

## Conditions studied

- Pheochromocytoma
- Paraganglioma

## Interventions

- **DIAGNOSTIC_TEST:** F-18 FDOPA PET/CT

## Key facts

- **NCT ID:** NCT05948137
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-21
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The study had to be prematurely stopped, falling short of the initial target due to prolonged shortages in the supply of 123I-MIBG.
- **Last updated:** 2023-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948137, "F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05948137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*